Informationen:
Fehler:
ID
30946
Beschreibung
Anti-Inflammatory Type II Monocyte Induction by Glatiramer Acetate (Copaxone) Treatment of Multiple Sclerosis; ODM derived from: https://clinicaltrials.gov/show/NCT00819195
Link
https://clinicaltrials.gov/show/NCT00819195
Stichworte
Versionen (1)
- 05.07.18 05.07.18 -
Rechteinhaber
See clinicaltrials.gov
Hochgeladen am
5. Juli 2018
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Multiple Sclerosis NCT00819195
Eligibility Multiple Sclerosis NCT00819195
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Multiple Sclerosis NCT00819195
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Multiple Sclerosis, Relapsing-Remitting
Item
relapsing-remitting (rr) ms patients (mcdonald criteria)
boolean
C0751967 (UMLS CUI [1])
Age
Item
ages 18-55
boolean
C0001779 (UMLS CUI [1])
Gender
Item
males and females
boolean
C0079399 (UMLS CUI [1])
EDSS
Item
edss score ≤5
boolean
C0451246 (UMLS CUI [1])
Copaxone Therapy naive
Item
no prior treatment with copaxone
boolean
C0528175 (UMLS CUI [1,1])
C0919936 (UMLS CUI [1,2])
C0919936 (UMLS CUI [1,2])
Adrenal Cortex Hormones | Interferon beta-1a | Interferon beta-1b | Washout Period Required
Item
prior treatment with corticosteroids or interferon-beta (-1a or -1b) is acceptable, provided there is a washout period of at least one month
boolean
C0001617 (UMLS CUI [1])
C0254119 (UMLS CUI [2])
C0244713 (UMLS CUI [3])
C1710661 (UMLS CUI [4,1])
C1514873 (UMLS CUI [4,2])
C0254119 (UMLS CUI [2])
C0244713 (UMLS CUI [3])
C1710661 (UMLS CUI [4,1])
C1514873 (UMLS CUI [4,2])
Tysabri | Novantrone | Cyclophosphamide
Item
treatment with tysabri, novantrone or cyclophosphamide
boolean
C1529600 (UMLS CUI [1])
C0282248 (UMLS CUI [2])
C0010583 (UMLS CUI [3])
C0282248 (UMLS CUI [2])
C0010583 (UMLS CUI [3])
Immunomodulation | Imuran | MYCOPHENOLATE | Methotrexate
Item
treatment with other immunomodulatory therapies (e.g. imuran, mycophenolate or methotrexate)
boolean
C1963758 (UMLS CUI [1])
C0699279 (UMLS CUI [2])
C0883242 (UMLS CUI [3])
C0025677 (UMLS CUI [4])
C0699279 (UMLS CUI [2])
C0883242 (UMLS CUI [3])
C0025677 (UMLS CUI [4])
Multiple Sclerosis, Primary Progressive | Multiple Sclerosis, Secondary Progressive
Item
primary-progressive (pp) and secondary-progressive (sp) multiple sclerosis
boolean
C0751964 (UMLS CUI [1])
C0751965 (UMLS CUI [2])
C0751965 (UMLS CUI [2])
Pregnancy
Item
pregnancy
boolean
C0032961 (UMLS CUI [1])